A MODEL STREPTOZOTOCIN MICE FOR STUDYING TYPE 2 DIABETES
DOI:
https://doi.org/10.62985/j.huit_ojs.vol26.no5.693Từ khóa:
Type 2 diabetes, STZ, chemically induced diabetes mouse model.Tóm tắt
Animal models are always necessary in pathological research, especially for type 2 diabetes (T2D). It is a chronic metabolic disorder with a high rate of increasing and involves many physiological systems. This study aims to provide a chemically induced type 2 diabetes mouse model by administering streptozotocin (STZ). Adult Swiss Albino mice were divided into three main groups to inject different dosages of STZ, specifically low dose, high dose 1, and high dose 2. As a result, mice in the high-dose group with a total of 160 mg/kg STZ for two injections were considered to obtain type 2 diabetes. After 4 months of experiment, the mice did not lose weight and acted normally. Characteristic metabolic alterations in type 2 diabetes contained an average fasting blood sugar level of over 150 mg/dL, fatty liver, damaged kidneys, and HbA1c levels of over 6.5%. It can be said that this research is the initial basic step to developing an effective type 2 diabetes mouse model in the future.
Tài liệu tham khảo
[1] International Diabetes Federation, IDF Diabetes Atlas, 10th ed. Brussels, Belgium: International Diabetes Federation, 2021.
[2] R. Singh, M. Gholipourmalekabadi, and S. H. Shafikhani, “Animal models for type 1 and type 2 diabetes: Advantages and limitations,” Front. Endocrinol., vol. 15, 2024, doi: https://doi.org/10.3389/fendo.2024.1359685
[3] J. Y. Fang, C. H. Lin, T. H. Huang, and S. Y. Chuang, “In vivo rodent models of type 2 diabetes and their usefulness for evaluating flavonoid bioactivity,” Nutrients, vol. 11, no. 3, 2019, doi: https://doi.org/10.3390/nu11030530
[4] D. N. Athmuri and P. A. Shiekh, “Experimental diabetic animal models to study diabetes and diabetic complications,” MethodsX, vol. 11, 2023, doi: https://doi.org/10.1016/j.mex.2023.102474
[5] D. Premilovac et al., “A new method for targeted and sustained induction of type 2 diabetes in rodents,” Sci. Rep., vol. 7, no. 1, 2017, doi: https://doi.org/10.1038/s41598-017-14114-4
[6] B. L. Furman, “Streptozotocin-induced diabetic models in mice and rats,” Curr. Protoc., vol. 1, no. 4, 2021, doi: https://doi.org/10.1002/cpz1.78
[7] O. M. Akinlade, B. V. Owoyele, and A. O. Soladoye, “Streptozotocin-induced type 1 and 2 diabetes in rodents: A model for studying diabetic cardiac autonomic neuropathy,” Afr. Health Sci., vol. 21, no. 2, pp. 719–727, 2021, doi: https://doi.org/10.4314/ahs.v21i2.30
[8] H. T. T. Nguyen, “Study of drug delivery system based on chitosan micro-nano particles and temperature, pH-sensitive biomedical hydrogels,” Ph.D. dissertation, Faculty of Chemical Engineering, Ho Chi Minh City University of Technology, Ho Chi Minh city, Vietnam, 2023.
[9] V. H. Nguyen, T. M. T. Ngo, H. L. Le, S. V. Huynh, N. M. L. Ngo, and N. H. Nguyen, “Evaluation of the effects of diabetes mellitus-causing streptozotocin on Vietnamese Swiss mice model,” J. 108 – Clin. Med. Pharm., (Special issue: Scientific Conference on the 70th anniversary of 108 Military Central Hospital), pp. 110–117, 2021.
[10] M. Zafar, S. N.-u.-H. Naqvi, M. Ahmed, and Z. A. Kaimkhani, “Altered kidney morphology and enzymes in streptozotocin induced diabetic rats,” Int. J. Morphol., vol. 27, no. 3, pp. 783–790, 2009, doi: https://doi.org/10.4067/S0717-95022009000300024
[11] G. Ouyang, N. Wang, J. Tong, W. Sun, J. Yang, and G. Wu, “Alleviation of taurine on liver injury of type 2 diabetic rats by improving antioxidant and anti-inflammatory capacity,” Heliyon, vol. 10, no. 7, 2024, doi: https://doi.org/10.1016/j.heliyon.2024.e28400
